by Scott Swigart | Sep 13, 2023 | News & Ideas
Using GenAI for Methodology Selection and Participant Screening In the first installment of this series, we explored how generative AI tools (GenAI), including ChatGPT and Claude, can be employed pre-project to come up to speed, refine research objectives, and develop...
by Kathryn Magliari | Sep 13, 2023 | News & Ideas
In pharma, “foresight” has become the new “insight”. More than ever before, insights teams are faced with the mounting pressure to identify winning opportunities for pipeline assets earlier and earlier in the discovery cycle. This increased emphasis on future success...
by Chelsey Merker | Sep 6, 2023 | News & Ideas
The most critical moment in the lifecycle of insights is often one that receives the least time and attention. Is it understanding the objectives clearly? Is it getting the sample design just right? The executive summary? All of these are critically important. Yet,...
by Chelsey Merker | Aug 29, 2023 | News & Ideas
Like many of the industries we serve, the life insurance industry is facing a pivotal moment. Several converging trends present both challenges and opportunities for life insurers to reinvent their business and remain relevant in a quickly evolving landscape. We...
by Abby Easley | Aug 23, 2023 | News & Ideas
The pharma industry is showing renewed interest in the neuro space, marking an exciting time in drug development, and a notable shift for healthcare-centric insights professionals. It’s clear that, to gather and generate insight into neurological patients, the...
by Alissa Sauer | Aug 22, 2023 | News & Ideas
B2B tech purchases seem like objective decisions – if you take the decision-maker’s word at face value. Most market researchers in B2B tech have been there: you’re 40 minutes into an in-depth interview with a CISO, and it’s going in circles. You’re trying to...
